Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Hepatology (Baltimore, Md.)|September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosisYameng Sun, Shuyan Chen, Xiaoqian Xu, et al.
The American Journal of Pathology|October 11, 2023
Insulin Determines Transforming Growth Factor β Effects on Hepatocyte Nuclear Factor 4α Transcription in HepatocytesRilu Feng, Chenhao Tong, Tao Lin, et al.
Scientific Reports|November 29, 2016
Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis BHong You, Yuanyuan Kong, Jinlin Hou, et al.
Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
BMC Gastroenterology|May 4, 2019
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaJian Sun, Huiguo Ding, Guofeng Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2017
On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosisShanshan Wu, Yuanyuan Kong, Hongxin Piao, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Yiwen Shi, Jialing Zhou, et al.
Gut|October 24, 2024
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activationFrederik Link, Yujia Li, Jieling Zhao, et al.
Pageof 11